These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 782731)

  • 41. Role of activated macrophages in nonspecific resistance to neoplasia.
    Hibbs JB
    J Reticuloendothel Soc; 1976 Sep; 20(3):223-31. PubMed ID: 789879
    [No Abstract]   [Full Text] [Related]  

  • 42. Adjuvant and antitumor activities of Nocardia cell-wall skeletons.
    Azuma I; Taniyama T; Yamawaki M; Sugimura K; Yamamura Y
    Gan; 1976 Oct; 67(5):733-6. PubMed ID: 797626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Introduction of "natural" killer' cells by BCG.
    Wolfe SA; Tracey DE; Henney CS
    Nature; 1976 Aug; 262(5569):584-6. PubMed ID: 785281
    [No Abstract]   [Full Text] [Related]  

  • 44. Relationship of expression of A cell-surface antigen on activated murine macrophages to tumor cell cytotoxicity.
    Kaplan AM; Bear HD; Kirk L; Cummins C; Mohanakumar T
    J Immunol; 1978 Jun; 120(6):2080-5. PubMed ID: 659893
    [No Abstract]   [Full Text] [Related]  

  • 45. An experimental screening for "systemic adjuvants of immunity" applicable in cancer immunotherapy.
    Mathé G; Kamel M; Dezfulian M; Halle-Pannenko O; Bourut C
    Cancer Res; 1973 Sep; 33(9):1987-97. PubMed ID: 4146853
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
    Wolmark N; Fisher B
    Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunological adjuvants in cancer immunotherapy.
    Baldwin RW
    Dev Biol Stand; 1977 Apr 13-15; 38():3-12. PubMed ID: 344097
    [No Abstract]   [Full Text] [Related]  

  • 48. Similarities among factors that render macrophages tumoricidal in lymphokine and interferon preparations.
    Schultz RM; Chirigos MA
    Cancer Res; 1978 Apr; 38(4):1003-7. PubMed ID: 346202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppression of cell-mediated tumour immunity by Corynebacterium parvum.
    Kirchner H; Glaser M; Herberman R
    Nature; 1975 Oct; 257(5525):396-8. PubMed ID: 170531
    [No Abstract]   [Full Text] [Related]  

  • 50. Nicotinamide adenine dinucleotide-splitting enzyme in normal, elicited and activated peritoneal macrophages of the mouse.
    Artman M; Seeley RJ
    J Reticuloendothel Soc; 1979 May; 25(5):479-87. PubMed ID: 222905
    [No Abstract]   [Full Text] [Related]  

  • 51. Macrophage functions in Biozzi mice.
    Dockrell HM; Taverne J; Lelchuk R; Depledge P; Brown IN; Playfair JH
    Immunology; 1985 Jul; 55(3):501-9. PubMed ID: 3894222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BCG-induced murine effector cells. I. Cytolytic activity in peritoneal exudates: an early response to BCG.
    Tracey DE; Wolfe SA; Durdik JM; Henney CS
    J Immunol; 1977 Sep; 119(3):1145-51. PubMed ID: 330748
    [No Abstract]   [Full Text] [Related]  

  • 53. The significance of macrophages in human and experimental tumors.
    Alexander P; Eccles SA; Gauci CL
    Ann N Y Acad Sci; 1976; 276():124-33. PubMed ID: 800321
    [No Abstract]   [Full Text] [Related]  

  • 54. Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide.
    Taniyama T; Holden HT
    Cell Immunol; 1979 Dec; 48(2):369-74. PubMed ID: 228871
    [No Abstract]   [Full Text] [Related]  

  • 55. Virus tumorigenesis and immunity: influence of immunostimulation and immunodepression.
    Friedman H; Ceglowski WS
    Johns Hopkins Med J Suppl; 1974; 3():187-209. PubMed ID: 4609083
    [No Abstract]   [Full Text] [Related]  

  • 56. Tumoricidal responses in vitro of peritoneal macrophages from conventionally housed and germ-free nude mice.
    Meltzer MS
    Cell Immunol; 1976 Mar; 22(1):176-81. PubMed ID: 776413
    [No Abstract]   [Full Text] [Related]  

  • 57. Monitoring of macrophage activation by immunoadjuvants in mice as judged by functional criteria.
    Puccetti P; Santoni A; Riccardi C
    Boll Soc Ital Biol Sper; 1978 Oct; 54(20):1936-42. PubMed ID: 380599
    [No Abstract]   [Full Text] [Related]  

  • 58. Suppressor T cells and suppressor macrophages induced by Corynebacterium parvum.
    Lichtenstein A; Murahata R; Sugasawara R; Zighelboim J
    Cell Immunol; 1981 Mar; 58(2):257-68. PubMed ID: 6452218
    [No Abstract]   [Full Text] [Related]  

  • 59. Paradoxical effects of immunopotentiators on tumors and tumor viruses.
    Morahan PS; Schuller GB; Snodgrass MJ; Kaplan AM
    J Infect Dis; 1976 Jun; 133 Suppl():A249-55. PubMed ID: 932503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New immunological approaches to the application of BCG vaccine for the treatments of tumors (acute leukoses).
    Ter-Grigorov VS; Yablokova TB; Levy DT; Rosenberg AM; Pisarenko NN; Levewbook IS; Graff IA
    J Hyg Epidemiol Microbiol Immunol; 1976; 20(1):25-31. PubMed ID: 57195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.